The Kansas City Medical Optimization (KCMO) score was developed to more accurately quantify the intensity of guideline-directed medical therapy (GDMT) for heart failure patients by averaging daily doses compared to target doses.
In a study with over 4,500 patients, baseline scores showed low average KCMO (38.8), indicating underutilization of optimal therapy, while a 1-year follow-up revealed slight declines in scores, suggesting challenges in improving GDMT intensity.
KCMO demonstrated the highest variability among scoring methods, implying it provides a clearer picture of differences in GDMT intensity among patients, but further research is needed to determine its impact on patient outcomes and quality of care.